Parameter | All patients | BT <37.5°C | BT ≥37.5°C | P value* |
---|---|---|---|---|
(n=258) | (n=106) | (n=152) | ||
Demographic characteristics | Â | Â | Â | Â |
Age, mean (SD) | 66.6(14.4) | 66.7(14.0) | 66.6(14.7) | 0.960 |
Sex, male, n (%) | 148(57.4) | 64(60.4) | 84(55.3) | 0.414 |
History of risk factors, n (%) | ||||
Hypertension | 133(51.6) | 58(54.7) | 75(49.3) | 0.395 |
Diabetes mellitus | 68(26.4) | 26(24.5) | 42(27.6) | 0.578 |
Smoking | 85(32.9) | 33(31.1) | 52(34.2) | 0.605 |
Drinking | 63(24.4) | 25(23.6) | 38(25.0) | 0.795 |
Dyslipidemia | 16(6.2) | 4(3.8) | 12(7.9) | 0.177 |
Previous stroke or TIA | 37(14.3) | 13(12.3) | 24(15.8) | 0.427 |
Atrial fibrillation | 142(55.0) | 63(59.4) | 79(52.0) | 0.236 |
Vital signs and laboratory parameters at baseline, mean (SD) | ||||
Systolic blood pressure, mm Hg | 142.0(26.0) | 141.6(25.5) | 142.2(26.4) | 0.868 |
Diastolic blood pressure, mm Hg | 81.8(13.9) | 81.1(12.8) | 82.3(14.8) | 0.489 |
Serum glucose, mmol/L | 8.3(3.0) | 7.8(2.2) | 8.6(3.5) | 0.052 |
Total cholesterol, mmol/L | 4.1(1.0) | 4.0(1.0) | 4.2(1.0) | 0.097 |
LDL-C, mmol/L | 2.4(0.8) | 2.4(0.8) | 2.5(0.8) | 0.382 |
Triglyceride, mmol/L | 1.5(1.0) | 1.4(0.8) | 1.6(1.2) | 0.095 |
HDL-C, mmol/L | 1.3(0.4) | 1.2(0.4) | 1.3(0.4) | 0.106 |
Creatinine, μmol/L | 78.0(25.5) | 81.1(27.7) | 75.8(23.6) | 0.097 |
Platelet count, ×109/μL | 172.1(66.6) | 173.9(73.1) | 170.8(62.0) | 0.723 |
White blood cell count, ×109/μL | 8.3(3.0) | 8.2(3.0) | 9.1(3.4) | 0.043 |
Pre-MT BT (°C) | 36.4(0.27) | 36.5(0.24) | 36.5(0.29) | 0.188 |
Arterial territory, n (%) | Â | Â | Â | 0.091 |
ICA occlusion | 67(26.0) | 23(21.7) | 44(28.9) | Â |
MCA occlusion | 134(51.9) | 65(61.3) | 69(45.4) | Â |
Tandem occlusion | 20(7.8) | 6(5.7) | 14(9.2) | |
Posterior circulation occlusion | 37(14.3) | 12(11.3) | 25(16.4) | |
TOAST classification, n (%) | Â | Â | Â | 0.427 |
Large-artery atherosclerosis | 93(36.0) | 37(34.9) | 56(36.8) | Â |
Cardio-embolism | 132(51.2) | 52(49.1) | 80(52.6) | Â |
Undetermined etiology | 33(12.8) | 17(16.0) | 16(10.5) | |
Anesthesia type, n (%) | Â | Â | Â | 0.241 |
 General anesthesia | 222(86.0) | 88(83.0) | 134(88.2) |  |
 Local anesthesia | 36(14.0) | 18(17.0) | 18(11.8) |  |
Procedure time, min, mean (SD) | 98.3(44.0) | 90.7(37.3) | 103.6(47.5) | 0.020 |
NIHSS score at baseline, median (IQR) | 17(13-22) | 11(13-23) | 16(11-20) | 0.014 |
ASPECTS, median (IQR) | 9(7-10) | 9(8-10) | 8(7-10) | 0.157 |
Length of stay, day, median (IQR) | 11(6-17) | 16(11-20) | 11(4-18) | 0.600 |
Number of devices passes, mean (SD) | 2.5(1.5) | 2.4(1.5) | 2.7(1.5) | 0.086 |
Successful recanalizationa, n (%) | 191(74.0) | 88(83.0) | 103(67.8) | 0.006 |
Intravenous thrombolysis, n (%) | 70(27.1) | 33(31.1) | 37(24.3) | 0.228 |